Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 3/2018

01-03-2018 | Concise Research Letter

Trends in Cannabis Use Disorder among Pregnant Women in the U.S., 1993–2014

Authors: Yuyan Shi, PhD, Sheng Zhong, PhD

Published in: Journal of General Internal Medicine | Issue 3/2018

Login to get access

Excerpt

Using data from the National Survey on Drug Use and Health, Brown et al. demonstrated that the prevalence of cannabis use increased from 2.4% to 3.9% from 2002 through 2014.1 Our study examines the prevalence of cannabis use disorder (CUD) and demographic disparities in prevalence among pregnancy-related hospitalizations during the period from 1993 to 2014, using an inpatient database. The findings are expected to inform clinicians who provide obstetric care and general internists who manage women contemplating pregnancy. …
Literature
1.
Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. 2017;317(2):207–9.CrossRefPubMedPubMedCentral
2.
Kuklina EV, Whiteman MK, Hillis SD, et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J. 2008;12(4):469–77.CrossRefPubMed
3.
4.
MacDorman MF, Matthews T, Declercq E. Trends in out-of-hospital births in the United States, 1990-2012. NCHS Data Brief. 2014(144):1–8.
5.
Metadata
Title
Trends in Cannabis Use Disorder among Pregnant Women in the U.S., 1993–2014
Authors
Yuyan Shi, PhD
Sheng Zhong, PhD
Publication date
01-03-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 3/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4201-0

Other articles of this Issue 3/2018

Journal of General Internal Medicine 3/2018 Go to the issue

Review Article

Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review

Clinical Practice: Clinical Images

Herpes Vegetans: an Unusual and Acyclovir-Resistant Form of HSV

Exercises in Clinical Reasoning

Exercises in Clinical Reasoning: Take a Time-Out and Reflect

Concise Research Letters

The Adrenal Incidentaloma: An Opportunity to Improve Patient Care

Capsule Commentary

Capsule Commentary on Zickmund et al., Racial, Ethnic, and Gender Equity in Veteran Satisfaction with Health Care in the Veterans Affairs Health Care System

Perspective

Baby Boomers and Beds: a Demographic Challenge for the Ages
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits